Lipiodol emulsion as a dual chemoradiation-sensitizer for pancreatic cancer treatment
Journal of Controlled Release · 2024
DOI: 10.1016/j.jconrel.2024.08.020 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Controlled Release, 2024. Verfasst von Shuang Zhu und 5 weiteren Autor:innen. Beteiligte Einrichtung: CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100…. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Emulsions, Gemcitabine, Ethiodized Oil. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Ministry of Science and Technology of the People's Republic of China, Key Research and Development Projects of Shaanxi Province, National Key Research and Development Program of China.
Abstract (Originalsprache)
Pancreatic ductal adenocarcinoma (PDAC) has a low survival rate and limited treatment options. Concurrent chemoradiotherapy is considered beneficial to improve tumor control, but the low drug bioavailability at tumor site and the low radiation tolerance of surrounding healthy organs greatly limits its effectiveness. Lipiodol, a natural drug carrier used in clinical transarterial chemoembolization, has shown potential as a radiosensitizer due to its high Z element iodine composition. Thus, this study aims to repurpose lipiodol as a sensitizer to simultaneously enhance chemo- and radiotherapy for PDAC. To this end, a stable lipiodol emulsion (IOE) loaded with gemcitabine is designed using clinically approved surfactants. At in vivo level, IOE demonstrates better radiotherapeutic effect than existing nanoradiosensitizers and enhanced drug bioavailability over free drug, leading to significant tumor inhibition and improved survival rates under concurrent chemo-radiotherapy. This may due to the sustained drug release, homogenous spatial distribution, and long-term retention ability of IOE in solid PDAC tumor. Furthermore, to better understand the functioning mechanism of drug-loaded IOE, in vitro study is conducted to reveal the ROS- and DNA damage-related therapeutic pathways. Lastly, a comprehensive toxicity assessment also proves the good biocompatibility and safety of as-prepared IOE. This study offers a clinically feasible sensitizer for simultaneous chemoradiotherapy and holds potential for other types of cancer treatment in clinics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, China; Spallation Neutron Source Science Center, Institute of Hig…
- CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, China; Center of Materials Science and Optoelectronics Engineerin…
- Shanxi Provincial Clinical Research Center for Interventional Medicine, First Hospital of Shanxi Medical University, Taiyuan 030001, China; Department of Oncological and Vascular Intervention, First Hospital of Shanxi M…
Förderung
- Ministry of Science and Technology of the People's Republic of China
- Key Research and Development Projects of Shaanxi Province
- National Key Research and Development Program of China
- Beijing Natural Science Foundation
- National Natural Science Foundation of China
- Institute of High Energy Physics Chinese Academy of Sciences
- Shanxi Province Natural Science Foundation
- Chinese Academy of Sciences
Zitieren
APA
Zhu, S., Gu, C., Gao, L., Du, S., Feng, D., & Gu, Z. (2024). Lipiodol emulsion as a dual chemoradiation-sensitizer for pancreatic cancer treatment. Journal of Controlled Release. https://doi.org/10.1016/j.jconrel.2024.08.020
Vancouver
Zhu S, Gu C, Gao L, Du S, Feng D, Gu Z. Lipiodol emulsion as a dual chemoradiation-sensitizer for pancreatic cancer treatment. Journal of Controlled Release. 2024. doi:10.1016/j.jconrel.2024.08.020
BibTeX
@article{Zhu2024,
author = {Zhu, Shuang and Gu, Chenglu and Gao, Long and Du, Shuanglong and Feng, Duiping and Gu, Zhanjun},
title = {Lipiodol emulsion as a dual chemoradiation-sensitizer for pancreatic cancer treatment},
journal = {Journal of Controlled Release},
year = {2024},
doi = {10.1016/j.jconrel.2024.08.020}
}
EUVIMED